DexCom, Inc. is a global leader in continuous glucose monitoring (CGM) technology, primarily serving individuals with diabetes. The company's core product ecosystem includes wearable sensors, such as the Dexcom G6 and G7, which transmit real-time glucose data to smart devices and dedicated receivers. In addition to its prescription-based systems, DexCom has expanded into the over-the-counter market with products like the Stelo Glucose Biosensor, targeting a broader demographic focused on metabolic health. The company generates revenue through the recurring sale of disposable sensors and durable transmitters. DexCom's digital health integrations, including the Dexcom Share app and Real-Time API, allow patients to share data with healthcare providers and caregivers. Headquartered in San Diego, California, the company maintains a significant international footprint with manufacturing facilities in the United States, Malaysia, and Ireland.
